Childhood rhabdomyosarcoma. Analysis of coordinated therapy and results.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005121:Extremities; D005260:Female; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007223:Infant; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009362:Neoplasm Metastasis; D009918:Orbital Neoplasms / Q000532:radiotherapy / Q000601:surgery; D011882:Radiotherapy, High-Energy; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014565:Urogenital Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014750:Vincristine / Q000627:therapeutic use
D003037:Cobalt Radioisotopes; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide